Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. (Q47202312)

11 January 2018

title

Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. (English)

1 reference

11 January 2018

8

Mack Roach

1 reference

11 January 2018

author name string

Jeff M Michalski

1

1 reference

11 January 2018

K Winter

2

1 reference

11 January 2018

James A Purdy

3

1 reference

11 January 2018

Carlos A Perez

4

1 reference

11 January 2018

Janice K Ryu

5

1 reference

11 January 2018

Matthew B Parliament

6

1 reference

11 January 2018

Richard K Valicenti

7

1 reference

11 January 2018

Howard M Sandler

9

1 reference

11 January 2018

Arnold M Markoe

10

1 reference

11 January 2018

James D Cox

11

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

11 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

11 January 2018

volume

58

1 reference

11 January 2018

issue

3

1 reference

11 January 2018

page(s)

735-742

1 reference

11 January 2018

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Interim report of toxicity from 3D conformal radiation therapy (3D-CRT) for prostate cancer on 3DOG/RTOG 9406, level III (79.2 Gy).

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Indications for and the significance of seminal vesicle irradiation during 3D conformal radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Fractionation and protraction for radiotherapy of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

Is the alpha/beta ratio for prostate cancer low?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

A simple analytic derivation suggests that prostate cancer alpha/beta ratio is low

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2901578-5

7 January 2021

10.1016/S0360-3016(03)01578-5

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

14967428

1 reference

11 January 2018